Back to Cancer Australia’s website
A monoclonal antibody directed against the CD52 antigen used in the treatment of B-cell and T-cell leukaemia.
Choose a cancer type from the drop-down menu, then enter a treatment related to treatment (such as surgery or a drug name) or supportive care.
Back to Cancer Australia’s website